Preoperative Measurement of Serum C-Reactive Protein: Is it Useful in the Differential Diagnosis of Adnexal Masses?:

作者: Adriana Yoshida , Sophie F. Derchain , Denise R. Pitta , Nathália Crozatti , Liliana A.L.A. Andrade

DOI: 10.5301/JBM.5000226

关键词:

摘要: BACKGROUND Serum biomarkers may help to discriminate malignant from benign adnexal masses with equivocal features on imaging. Adequate discrimination of such tumors is crucial for referring patients either a specialized cancer center or nonspecialized gynecology service. AIM We aimed investigate whether the preoperative level serum C-reactive protein (CRP), alone combined CA125 and menopausal status in Ovarian Score (OVS), useful prediction malignancy women ovarian tumors. METHODS This cross-sectional study included 293 who underwent surgery tertiary center. Receiver operating characteristic (ROC) areas under curves (AUC) CRP, OVS were calculated different scenarios, as well their sensitivity specificity, using standard cutoff points (for 10 mg/L; CA125, 35 U/mL). RESULTS performed significantly better than CRP differentiation disease epithelial (EOC) (AUC = 0.86 0.79 OVS, 0.73 CRP). superior only borderline advanced stages EOC non-EOC. Sensitivity specificity 52.5% 83%, respectively, 77.9% 66.7% 71.3% 67.8% OVS. CONCLUSIONS good cancer. The addition enhanced relatively low discriminatory power isolated CRP.

参考文章(31)
Ian Jacobs, Robert C. Bast, The CA 125 tumour-associated antigen: a review of the literature Human Reproduction. ,vol. 4, pp. 1- 12 ,(1989) , 10.1093/OXFORDJOURNALS.HUMREP.A136832
Ie-Ming Shih, Robert J. Kurman, Ovarian Tumorigenesis : A Proposed Model Based on Morphological and Molecular Genetic Analysis American Journal of Pathology. ,vol. 164, pp. 1511- 1518 ,(2004) , 10.1016/S0002-9440(10)63708-X
JENNIFER A. BENNETT, ESTHER OLIVA, Pathology of the adnexal mass Clinical Obstetrics and Gynecology. ,vol. 58, pp. 3- 27 ,(2015) , 10.1097/GRF.0000000000000082
YAPING LU, SEN HUANG, PING LI, BINGYU CHEN, WEILING LIU, ZHIQING CHEN, FUBO YIN, Prognostic evaluation of preoperative serum C-reactive protein concentration in patients with epithelial ovarian cancer Experimental and Therapeutic Medicine. ,vol. 9, pp. 2003- 2007 ,(2015) , 10.3892/ETM.2015.2350
Britton Trabert, Ligia Pinto, Patricia Hartge, Troy Kemp, Amanda Black, Mark E. Sherman, Louise A. Brinton, Ruth M. Pfeiffer, Meredith S. Shiels, Anil K. Chaturvedi, Allan Hildesheim, Nicolas Wentzensen, Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial Gynecologic Oncology. ,vol. 135, pp. 297- 304 ,(2014) , 10.1016/J.YGYNO.2014.08.025
Meghan A. McSorley, Anthony J. Alberg, Diane S. Allen, Naomi E. Allen, Louise A. Brinton, Joanne F. Dorgan, Michael Pollak, Yuzhen Tao, Kathy J. Helzlsouer, C-reactive protein concentrations and subsequent ovarian cancer risk. Obstetrics & Gynecology. ,vol. 109, pp. 933- 941 ,(2007) , 10.1097/01.AOG.0000257126.68803.03
Joydeb Kumar Kundu, Young-Joon Surh, Emerging avenues linking inflammation and cancer Free Radical Biology and Medicine. ,vol. 52, pp. 2013- 2037 ,(2012) , 10.1016/J.FREERADBIOMED.2012.02.035
Bo Zhou, Bin Shu, Jue Yang, Jing Liu, Tao Xi, Yingying Xing, C-reactive protein, interleukin-6 and the risk of colorectal cancer: a meta-analysis Cancer Causes & Control. ,vol. 25, pp. 1397- 1405 ,(2014) , 10.1007/S10552-014-0445-8
R.C. BAST, D. BADGWELL, Z. LU, R. MARQUEZ, D. ROSEN, J. LIU, K.A. BAGGERLY, E.N. ATKINSON, S. SKATES, Z. ZHANG, A. LOKSHIN, U. MENON, I. JACOBS, K. LU, New tumor markers: CA125 and beyond International Journal of Gynecological Cancer. ,vol. 15, pp. 274- 281 ,(2005) , 10.1111/J.1525-1438.2005.00441.X